Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data

BACKGROUND: Management of cancer-associated venous thromboembolism (VTE) is essential in cancer treatment selection and prognosis. However, currently, no method exists for assessing VTE risk associated with advanced lung cancer. Therefore, we assessed VTE risk, including driver gene mutation, in adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsubata, Yukari, Kawakado, Keita, Hamai, Kosuke, Furuya, Naoki, Yokoyama, Toshihide, Saito, Ryota, Nakamura, Atsushi, Masuda, Takeshi, Hamaguchi, Megumi, Kuyama, Shoichi, Honda, Ryoichi, Senoo, Tadashi, Nakanishi, Masamoto, Hotta, Takamasa, Yamasaki, Masahiro, Ishikawa, Nobuhisa, Fujitaka, Kazunori, Kubota, Tetsuya, Kobayashi, Kunihiko, Isobe, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823025/
https://www.ncbi.nlm.nih.gov/pubmed/36357710
http://dx.doi.org/10.1007/s10147-022-02257-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823025/
https://www.ncbi.nlm.nih.gov/pubmed/36357710
http://dx.doi.org/10.1007/s10147-022-02257-y

Ejemplares similares